The U.S. Food and Drug Administration has extended its review for the expanded use of Travere Therapeutics’ drug to treat a ...

Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...

One 26-year-old mother of six in Arkansas is reaching out for the public’s help as she battles stage 5 kidney failure and ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...

The incidence of kidney disease is substantially higher in patients with Down syndrome than in control individuals from the ...

Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and ...

Vertex on track for “five launches in five disease areas over a five-year period” through emerging pain and renal franchises.

HPT, HP, and HK in the 7MM and a moderate sales growth forecast highlight market opportunities. Significant unmet needs and emerging pipeline products present avenues for market expansion and ...

Officer Quas’Jon “Q” Flowers, 25, and a two-year veteran of the Albany Police Department, was diagnosed with advanced kidney ...

The U.S. Food and Drug Administration has extended its review for the expanded use of Travere Therapeutics’ drug to treat a ...

As the health care delivery landscape continues to evolve, the need to advocate for policies that affect patients and the ...